Universal Molecular Detection Starts with
Better Reagents
F&N BIO is developing the ALFA™ Platform—a new generation of molecular detection reagents designed to transform diverse analytes into fluorescence- and amplification-compatible molecular signals.
Aptamer-Linked Fluorescence & Amplification
ALFA is a reagent platform—not an instrument. The technology converts molecular recognition events into two complementary outputs: a fluorescence signal and an amplification-compatible nucleic acid barcode. This enables existing laboratory instruments to analyze new classes of biological targets.
Target Molecule
Proteins, metabolites, hormones, toxins, cytokines, small molecules
ALFA™ Reagent
Aptamer-linked fluorescence & amplification conversion
Fluorescence Signal
Direct fluorescence readout compatible with existing readers
DNA Barcode
Amplification-compatible nucleic acid barcode for qPCR, dPCR, NGS
Designed to Work with Existing Laboratory Platforms
Rather than replacing existing laboratory instruments, ALFA expands their analytical capabilities by enabling detection of proteins, metabolites, hormones, toxins, cytokines, and other biomolecules using familiar fluorescence and nucleic acid workflows.
Enabling Discovery Across Disciplines
The ALFA™ Platform is designed to support diverse applications across diagnostics, research, and commercial markets.
Autoimmune Disease
Autoantibody and cytokine profiling for autoimmune diagnostics
Cancer
Tumor biomarker detection and monitoring
Infectious Disease
Pathogen and host-response molecular analysis
Drug Discovery
Compound screening and pharmacological profiling
Environmental Monitoring
Contaminant and toxin detection in environmental samples
Food Safety
Allergen, pathogen, and contaminant testing
Biomarker Discovery
High-throughput molecular discovery workflows
Precision Medicine
Patient-specific molecular profiling and treatment selection
Designed for Platform Integration
F&N BIO is developing ALFA as a reagent technology designed to integrate with existing laboratory ecosystems. Rather than developing new instrumentation, our strategy is to enhance existing laboratory workflows through innovative molecular reagents.
Global Markets
The ALFA™ Platform addresses multiple high-growth market segments across diagnostics, research, and pharmaceutical industries.
Total Addressable Market spans multiple billion-dollar segments
About F&N BIO
Engineering the Future of Molecular Detection
F&N BIO Inc. is a Canadian biotechnology company dedicated to developing next-generation molecular detection reagents that expand the capabilities of existing laboratory technologies. Our mission is to enable researchers, clinicians, and industry partners to detect a broader range of biological molecules using familiar fluorescence- and nucleic acid-based workflows.
Our flagship technology, the ALFA™ Platform (Aptamer-Linked Fluorescence & Amplification), is a proprietary reagent system that converts molecular recognition events into fluorescence and amplification-compatible molecular outputs.
Rather than developing new analytical instruments, F&N BIO focuses on creating innovative reagent technologies that integrate seamlessly into existing laboratory workflows. This reagent-first strategy enables rapid adoption, scalable commercialization, and future opportunities for collaboration with instrument manufacturers, diagnostics companies, and life science partners worldwide.
To become a global leader in molecular reagent technologies by creating intelligent biochemical interfaces that connect diverse biological targets with next-generation analytical platforms and AI-enabled molecular data analysis.
To accelerate scientific discovery and improve human health by developing innovative molecular detection reagents that make complex biological information easier to measure, analyze, and interpret.
Contact F&N BIO
Interested in learning more about the ALFA™ Platform or exploring partnership opportunities?